FILED UNDER SOMETHINGISRAELI >> Health & Lifestyle
Scientists and doctors from Israel's science and technology university the Technion are taking part in a project which will see five Technion facilities join together to locate genes that will help them understand how to develop drug therapy that is tailored to individual patients.
It is hoped that by making the treatment very specific, it will help patients much more than current practices of generic treatment which is to offer all patients similar treatments such as a dosage of drugs.
Much treatment these days is done on the basis of trial and error to patients who are given standard dosages based on general usage, rather than based on their own genes. The results of genetic treatment can be devastating to patients who can suffer as a result, whereas the personalised approach would minimise adverse reaction to treatment.
“Taking part in the project are 10 scientists from the Technion and physicians from Rambam, Carmel and Haemek Medical Centres, together with their assistants,” said Professor Ron Pinter of the Technion’s Faculty of Computer Science. “Five faculties – Medicine, Industrial Engineering and Management, Bio-Technology and Food Engineering, Bio-Medical Engineering and Computer Science – have joined together for this. The computer scientists among us will develop methods to analyse the genetic data and genomes that will be provided to them by the physicians and scientists.”
In the future, a patient may eventually have a credit card device which will store all their personal details which in turn will allow better development of drugs that can help patients as the data will be able to quickly and easily inform medical experts what drugs a person is suited to.
For more information: www.technion.ac.il